[
  {
    "ts": "2025-08-19T03:15:44+00:00",
    "headline": "Goldman Sachs Reiterated a Buy Rating on Vertex Pharmaceuticals (VRTX), Kept the PT Unchanged",
    "summary": "Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) is one of the Most Profitable Large Cap Stocks to Buy According to Analysts. On August 11, Goldman Sachs analyst Salveen Richter reiterated a Buy rating on Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) with a price target of $624. The reiterated bullish sentiment follows the announcement of strong fiscal second-quarter results by the […]",
    "url": "https://finance.yahoo.com/news/goldman-sachs-reiterated-buy-rating-031544160.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "9e66f5f9-da26-300c-96d7-f988b87f7739",
      "content": {
        "id": "9e66f5f9-da26-300c-96d7-f988b87f7739",
        "contentType": "STORY",
        "title": "Goldman Sachs Reiterated a Buy Rating on Vertex Pharmaceuticals (VRTX), Kept the PT Unchanged",
        "description": "",
        "summary": "Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) is one of the Most Profitable Large Cap Stocks to Buy According to Analysts. On August 11, Goldman Sachs analyst Salveen Richter reiterated a Buy rating on Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) with a price target of $624. The reiterated bullish sentiment follows the announcement of strong fiscal second-quarter results by the […]",
        "pubDate": "2025-08-19T03:15:44Z",
        "displayTime": "2025-08-19T03:15:44Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/1072f698caaab685c17bd7da04c05995",
          "originalWidth": 1456,
          "originalHeight": 816,
          "caption": "Goldman Sachs Reiterated a Buy Rating on Vertex Pharmaceuticals (VRTX), Kept the PT Unchanged",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/l0DSaAhjgYrGYMIp84u.Dg--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/1072f698caaab685c17bd7da04c05995.cf.webp",
              "width": 1456,
              "height": 816,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/MOpM93.qarjxsgAhhmtxCQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/1072f698caaab685c17bd7da04c05995.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/goldman-sachs-reiterated-buy-rating-031544160.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/goldman-sachs-reiterated-buy-rating-031544160.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "VRTX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]